Accent Microcell

Accent Microcell Diluted EPS

The Diluted Earnings per Share of Accent Microcell (ACCENTMIC.NS) as of Nov 4, 2026 is 29.72 INR. In the previous year, Diluted Earnings per Share was 35.33 INR — a change of -15.86% (lower).

Diluted EPS

29.72INR

YoY

-15.86%

Last updated:

Diluted Earnings per Share of Accent Microcell is 2025 29.72 INR. Diluted Earnings per Share of Accent Microcell was 2024 35.33 INR. It decreases by -15.86% lower compared to the previous year.

The Accent Microcell Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2023
333.36 INR
Jan 1, 2024
35.33 INR
Jan 1, 2025
29.72 INR
The Accent Microcell Diluted EPS history
YEARDiluted EPSYoY
29.72INR-15.86%
35.33INR-89.40%
333.36INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Accent Microcell Stock analysis

What does Accent Microcell do? Accent Microcell Ltd develops, processes, and markets a wide range of pharmaceutical products including bulk drugs, formulations in all forms, feed and dietary supplements, and healthcare products across allopathic, ayurvedic, umami, homeopathic, and other branches. The company manufactures and sells antibiotics, herbal, bacteriological, and biological products, as well as insecticides, pesticides, fungicides, and disinfectants. With over 200 products in its portfolio, Accent Microcell targets therapeutic segments in human and veterinary healthcare, offering both raw materials and finished preparations for diverse medical applications. The company's product range includes microcrystalline cellulose powder and alpha cellulose powder, which are used as pharmaceutical excipients. Accent Microcell Limited deals in all kinds of drugs and medicines, covering various therapeutic areas such as antibiotics, herbal remedies, and veterinary applications. Its business model focuses on manufacturing, importing, and exporting these products to meet demand in multiple healthcare sectors. Accent Microcell Ltd's revenue streams come from selling bulk drugs, pharmaceutical formulations, and healthcare products to distributors, pharmacies, and veterinary suppliers. The company's diverse portfolio of over 200 products ensures steady demand across different therapeutic segments, supporting consistent sales in both human and veterinary healthcare markets. Accent Microcell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accent Microcell stock

Diluted Earnings per Share of Accent Microcell is 29.72 INR in 2025.

Diluted Earnings per Share of Accent Microcell changed from 35.33 INR to 29.72 INR, representing a -15.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Accent Microcell since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Accent Microcell

All Key Metrics — Accent Microcell